 Nephropathy model genetic hypertension experimental diabetes Enalapril versus hydralazine metoprolol therapy effects angiotensin-converting enzyme inhibitor enalapril conventional antihypertensive regimen hydralazine metoprolol kidney function albuminuria glomerular ultrastructure hypertensive diabetic nondiabetic rats Diabetes streptozocin wk age hypertensive SHR rats Antihypertensive drugs drinking water time induction diabetes groups Blood pressure reduction equal diabetic nondiabetic SHR enalapril hydralazine metoprolol diabetic SHR rats rise serum creatinine wk diabetic rats antihypertensive regimen nondiabetic rats drug albuminuria diabetic nondiabetic SHR rats similar degree Enalapril combination hydralazine metoprolol decreased glomerular basement membrane thickness glomerular volume diabetic nondiabetic SHR rats significant effect fractional mesangial volume antihypertensive therapy development albuminuria glomerular basement membrane thickening glomerular hypertrophy rat presence absence diabetes specific benefit angiotensin-converting enzyme inhibition hypertensive models nephropathy Human studies effects different classes antihypertensive drugs kidney function proteinuria glomerular morphology